Zogenix, Inc. (NASDAQ:ZGNX)’s shares decreased 17.22% to $4.54. The company on Mar. 5 reported financial results for the fourth quarter and full year ended December 31, 2013. Total revenues for the fourth quarter 2013, which consist of net product revenue and service and other revenue, were $9.9 million, up from $9.5 million in the fourth quarter 2012. Zogenix, Inc. (NASDAQ:ZGNX) stock opened at $.92 in last session, and closed at $3.51, while the day range of ZGNX stock is $3.35-$3.98.The stock showed a negative weekly performance of -21.86%.
Merck & Co., Inc.(NYSE:MRK) a global health care company recently shared it results on its investigational house dust mite sublingual immunotherapy tablet (MK-8237) which is currently at mid-stage clinical trial. The company presented this data during 2014 Annual Meeting of the AmericanAcademy of Allergy, Asthma & Immunology (AAAAI) in San Diego for the first time. Around 124 patents with age group of 18 and over participated in the clinical trials. According to the reports, MK-8237 was significantly effective in reducing nasal symptoms by 49% with higher dose and 27% with lower dose. The company is currently waiting U.S. approval decisions for regular production and distribution in the market. Merck & Co., Inc. (NYSE:MRK) stock opened at $56.39, in last session and closed at $56.81, by gained 0.21%. The 52 week range was $43.51-$57.65.Company’s market capitalization is $167.06 billion.
Bristol-Myers Squibb (NYSE:BMY) was the recipient of unusually large options trading on Wednesday. Stock traders acquired 11,668 call options on the company,AmericanBankingNews.com reports. This is an increase of approximately 122% compared to the typical volume of 5,245 call options. Bristol-Myers Squibb Co (NYSE:BMY) stock loosed -1.06% and finished the last session at $55.24.The EPS of the stock remained 1.55. Company’s market capitalization is $91.16 billion.
Johnson & Johnson (NYSE:JNJ) shares are currently priced at 16.03x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 8.20x earnings multiple. And for those looking to make a return holding the stock, the company pays shareholders $2.64 per share annually in dividends, yielding 2.80%. Johnson & Johnson (NYSE:JNJ) stock opened the session at $92.82, and closed the session at $93.60. The 52 week range of the JNJ stock remained $78.20-$95.99 and the day range was $92.65-$93.62.
Leave a Reply